I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 23% ± 8% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 19% ± 2% | |
| myeloid cell | 4 studies | 17% ± 1% | |
| type I pneumocyte | 4 studies | 20% ± 5% | |
| macrophage | 4 studies | 20% ± 2% | |
| hepatocyte | 3 studies | 24% ± 9% | |
| dendritic cell | 3 studies | 30% ± 9% | |
| natural killer cell | 3 studies | 20% ± 4% | |
| abnormal cell | 3 studies | 20% ± 3% | |
| alveolar macrophage | 3 studies | 18% ± 3% | |
| astrocyte | 3 studies | 20% ± 3% |
